1GOMARD-MENNESSON E,RUIVARD M,KOENIG M,et al.Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus:26 cases[J].Lupus,2006,15(4):223-231. 被引量：1
2WANG S W,CHENG T T.Systemic lupus erythematosus with refractory hemolytic anemia effectively treated with cyclosporin A:a case report[J].Lupus,2005,14(6):483-485. 被引量：1
3ALBA P,KARIM M Y,HUNT B J.Mycophenolate mofetil as a treatment for autoimmune hemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome[J].Lupus,2003,12(8):633-635. 被引量：1
4LINDHOLM C,BRJESSON-ASP K,ZENDJANCHI K,et al.Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus[J].J Rheumatol,2008,35(5):826-833. 被引量：1
6PAVITHRAN K,RAJI N I,THOMAS M.Aplastic anemia complicating systemic lupus erythematosus:report of a case and review of the literature[J].Rheumatol Int,2002,22(6):253-255. 被引量：1
2Levesque MC,Clair EW St.B cell directed therapies for autoimmune disease and correlates of disease response and relapse.J Allergy Clin Immunol,2008,1:13-21. 被引量：1
3Virgolini L,Marzocchi V.Rituximab in autoimmune diseases.Biom Pharma,2004,58:299-309. 被引量：1
4Podolskaya A,Stadermann M,Pilkington C,et al.B cell depletion therapy for 19 patients with refractory systemic lupus erythe matosus.Arch Dis Child,2008,93:401-406. 被引量：1
5Reynolds JA,Toescu V,Yee CS,et al.Effects of rituximab on resistant SLE disease including lung involvement.Lupus,2009,18;67-73. 被引量：1
6J6nsd6ttir T,Gunnarsson I,Risselada A,et al.Treatment of refractory SLE with rituximab plus cyclophosphamide:clinical effects,serological changes,and predictors of response.Ann Rheum Dis,2008,67:330-334. 被引量：1
7Gunnarsson IV A,Sundelin B,Jonsdottir T,et al.Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.Arthritis Rheum,2007,56:1263-1272. 被引量：1
8Tokunaga M,Saito K,Kawabata D,et al.Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.Ann Rheum Dis,2007,66 (4):470-475. 被引量：1
9Keogh KA,Ytterberg SR,Fervenza FC,et al.Rituximab for refractory Wegener's granulomatosis:report of a prospective,open label pilot trial.Am J Respir Crit Care Med,2006,173:180-187. 被引量：1
10Levine TD.Rituximab in the treatment of dermatomyositis:an open-label pilot study.Arthritis Rheum,2005,52:601-607. 被引量：1
7Brunner HI, Gladman DD, Ibanez D, et al. Difference in disease fea- tures between childhood - onset and adult - onset systemic lupus erythe- matosus [ J]. Arthritis Rheum ,2008,58 ( 2 ) :556 - 562. 被引量：1
8Font J,Cervera R,Ramos-Casals M,et rd.Clusters of clinical and im- munologic features in systemic lupus erythematosus:analysis of 600 patientsfrom a single center[J].Semin Arthritis Rheum, 2004,33 (4) : 217-230. 被引量：1
9Dias AM,Couto MC,Duarte CC,et a1.Whiceblood cellcountab-normalities and infections in one-year follow-up of124patients with SLE[J].Ann N Y Acad Sci,2009,l17(3):103-107. 被引量：1
10Mooventhan A,Nivethitha L.Effects of acupuncture and massage on pain,quality of sleep and health related quality of life in patient with systemic lupus erythematosus[J].J Ayurveda Integr Med,2014,5(3):186-189. 被引量：1
